$0.664500
0.00530.80%
At Close: -
$0.669600
0.00510.77%
After Hours: 7:46 PM EDT
15 minutes delayed
Comments
Loading...
Bionano Genomics
BNGONASDAQ
Bionano Genomics (NASDAQ:BNGO) Stock, Analyst Ratings, Price Targets, Forecasts
Bionano Genomics Inc has a consensus price target of $5.15 based on the ratings of 6 analysts. The high is $9 issued by Oppenheimer on February 6, 2023. The low is $1.75 issued by EF Hutton on May 25, 2023. The 3 most-recent analyst ratings were released by BTIG, Scotiabank, and BTIG on May 16, 2024, March 7, 2024, and August 10, 2023, respectively. With an average price target of $6 between BTIG, Scotiabank, and BTIG, there's an implied 796.06% upside for Bionano Genomics Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
BTIG
Scotiabank
EF Hutton
Oppenheimer
BTIG
1calculated from analyst ratings
Analyst Ratings for Bionano Genomics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/16/2024 | Buy Now | 198.69% | BTIG | Mark Massaro | $3 → $2 | Maintains | Buy | Get Alert |
| 03/07/2024 | Buy Now | 796.06% | Scotiabank | Sung Ji Nam | $7 → $6 | Maintains | Sector Outperform | Get Alert |
| 11/13/2023 | Buy Now | — | Maxim Group | Jason McCarthy | — | Downgrade | Buy → Hold | Get Alert |
| 08/10/2023 | Buy Now | 1393.43% | BTIG | Mark Massaro | $2 → $10 | Maintains | Buy | Get Alert |
| 05/25/2023 | Buy Now | 161.35% | EF Hutton | — | → $17.5 | Initiates | → Buy | Get Alert |
| 05/18/2023 | Buy Now | 198.69% | BTIG | Mark Massaro | $30 → $20 | Maintains | Buy | Get Alert |
| 04/24/2023 | Buy Now | 348.03% | BTIG | Mark Massaro | $30 → $30 | Maintains | Buy | Get Alert |
| 03/10/2023 | Buy Now | 348.03% | BTIG | Mark Massaro | → $30 | Maintains | Buy | Get Alert |
| 02/06/2023 | Buy Now | 1244.09% | Oppenheimer | Francois Brisebois | $120 → $90 | Maintains | Outperform | Get Alert |
| 02/05/2023 | Buy Now | 422.7% | BTIG | Mark Massaro | $35 → $35 | Maintains | Buy | Get Alert |
| 01/05/2023 | Buy Now | 497.37% | Scotiabank | Sung Ji Nam | → $40 | Initiates | → Sector Outperform | Get Alert |
| 12/12/2022 | Buy Now | 422.7% | BTIG | Mark Massaro | → $35 | Assumes | → Buy | Get Alert |
| 07/18/2022 | Buy Now | 1692.11% | Oppenheimer | Francois Brisebois | → $120 | Assumes | → Outperform | Get Alert |
| 04/07/2022 | Buy Now | 945.4% | BTIG | Sung Ji Nam | $100 → $70 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Bionano Genomics (BNGO) stock?
The latest price target for Bionano Genomics (NASDAQ:BNGO) was reported by BTIG on May 16, 2024. The analyst firm set a price target for $2.00 expecting BNGO to rise to within 12 months (a possible 198.69% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Bionano Genomics (BNGO)?
The latest analyst rating for Bionano Genomics (NASDAQ:BNGO) was provided by BTIG, and Bionano Genomics maintained their buy rating.
When was the last upgrade for Bionano Genomics (BNGO)?
There is no last upgrade for Bionano Genomics
When was the last downgrade for Bionano Genomics (BNGO)?
The last downgrade for Bionano Genomics Inc happened on November 13, 2023 when Maxim Group changed their price target from N/A to N/A for Bionano Genomics Inc.
When is the next analyst rating going to be posted or updated for Bionano Genomics (BNGO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bionano Genomics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bionano Genomics was filed on May 16, 2024 so you should expect the next rating to be made available sometime around May 16, 2025.
Is the Analyst Rating Bionano Genomics (BNGO) correct?
While ratings are subjective and will change, the latest Bionano Genomics (BNGO) rating was a maintained with a price target of $3.00 to $2.00. The current price Bionano Genomics (BNGO) is trading at is $0.67, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.